Skip to main content
  1. Market Insights
  2. Health
  3. Mental Health

Anxiety and Related Sleep Disorders - Australia

Australia
  • Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$50.98m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.49%, resulting in a market volume of US$49.74m by 2029.
  • In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
  • In relation to total population figures, per person revenues of US$22.58 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

In-Scope

  • Pharmaceutical sales and consumption of anxiolytics
  • Pharmaceutical sales and consumption hypnotics and sedatives

Out-Of-Scope

  • Non-mental health related sleep disorders
  • Any other anxiety medications
  • Psychotherapy
Anxiety and Related Sleep Disorders: market data & analysis - Cover

Market Insights report

Anxiety and Related Sleep Disorders: market data & analysis

Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Patients

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Anxiety and Related Sleep Disorders market in Australia is experiencing steady growth due to increasing customer preferences for natural remedies and a growing awareness of mental health issues.

    Customer preferences:
    Customers in Australia are increasingly seeking natural remedies for anxiety and related sleep disorders. This shift in preferences is driven by a desire for holistic and non-invasive treatments, as well as concerns about the potential side effects of pharmaceutical medications. As a result, there is a growing demand for herbal supplements, aromatherapy products, and mindfulness practices that can help manage anxiety and improve sleep quality.

    Trends in the market:
    One major trend in the Anxiety and Related Sleep Disorders market in Australia is the rising awareness of mental health issues. Australians are becoming more open about discussing their mental health and seeking professional help when needed. This increased awareness has led to a greater recognition of anxiety and related sleep disorders as legitimate health concerns, driving the demand for products and services that can help manage these conditions.Another trend in the market is the growing popularity of alternative therapies. Australians are increasingly turning to complementary and alternative medicine (CAM) practices, such as acupuncture, yoga, and meditation, to manage anxiety and improve sleep. These therapies are seen as more natural and holistic approaches to health and wellness, aligning with the customer preference for non-invasive treatments.

    Local special circumstances:
    Australia has a high prevalence of anxiety and related sleep disorders, which contributes to the growth of the market. According to the Australian Bureau of Statistics, anxiety-related conditions are the most common mental health disorders in the country, affecting approximately 14% of the population. This high prevalence creates a significant market opportunity for products and services that can effectively address these conditions.Additionally, the Australian government has been actively promoting mental health and wellbeing initiatives, which further supports the growth of the Anxiety and Related Sleep Disorders market. The government has invested in campaigns to reduce the stigma surrounding mental health and increase access to mental health services. These initiatives have raised awareness and encouraged individuals to seek help for their anxiety and related sleep disorders, driving the demand for products and services in the market.

    Underlying macroeconomic factors:
    The overall growth of the Anxiety and Related Sleep Disorders market in Australia is also influenced by macroeconomic factors such as disposable income and healthcare expenditure. As disposable income increases, individuals have more resources to spend on products and services that can help manage their anxiety and improve their sleep. Similarly, higher healthcare expenditure allows for greater access to mental health services and treatments, driving the demand for products in the market.In conclusion, the Anxiety and Related Sleep Disorders market in Australia is experiencing steady growth due to increasing customer preferences for natural remedies, a growing awareness of mental health issues, and local special circumstances such as a high prevalence of these conditions and government support for mental health initiatives. These factors, along with underlying macroeconomic factors, contribute to the development of the market in Australia.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

    Additional Notes:

    The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    Anxiety and Related Sleep Disorders: market data & analysis - BackgroundAnxiety and Related Sleep Disorders: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    U.S. Mental Health Issues - Statistics & Facts

    Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.